Document Detail


Increased ratio of vascular endothelial growth factor to semaphorin3A is a negative prognostic factor in human meningiomas.
MedLine Citation:
PMID:  20337947     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Semaphorin3A (SEMA3A) is an anti-angiogenic factor which is expressed in human meningiomas in association with low microvessel density (MVD). It competes with vascular endothelial growth factor (VEGF) for receptor neuropilin-1 (NRP-1). The ratio between VEGF and SEMA3A has been recently demonstrated to regulate neo-angiogenesis, proliferation and progression of tumors. To clarify the involvement of these proteins in the above-mentioned phenomena, we analyzed the immunohistochemical expression of SEMA3A, VEGF and NRP-1 and their correlation with MVD in a series of 48 cases of meningioma with different histotype and histological grade. SEMA3A and VEGF expression was encountered in about half the cases, although at different levels. NRP-1 staining was evidenced in the vessels within all but two tumors and in the neoplastic cells of 18/48 meningiomas. A negative significant correlation emerged between SEMA3A amount and MVD; on the other hand, high VEGF levels appeared to be significantly associated with high MVD. A high VEGF/SEMA3A was significantly associated with high histological grade, proliferation index and MVD as well as with a higher recurrence rate of the meningiomas. Present data suggest that the balance between the expression of the pro-angiogenic factor VEGF and the anti-angiogenic SEMA3A may be involved in the regulation of neo-angiogenesis and proliferation in meningiomas, representing also a predictor of recurrences in these tumors. Further validation of our results may open the way for the use of drugs targeting not only VEGF, but also NRP-1 and SEMA3A to prevent recurrences of meningiomas.
Authors:
Valeria Barresi; Giovanni Tuccari
Related Documents :
15492987 - Expression of vascular endothelial growth factor (vegf) and its receptors (vegf-r1 [flt...
18681907 - Liposome-based vascular endothelial growth factor-165 transfection with skeletal myobla...
20006737 - Pigment epithelium-derived factor inhibits vascular endothelial growth factor-and inter...
14598357 - Effects of major liver resection, with or without recombinant bactericidal/permeability...
8269197 - Free radicals, antioxidants, and endothelial cell damage after percutaneous translumina...
18615577 - Formation of kv2.1-fak complex as a mechanism of fak activation, cell polarization and ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2010-3-10
Journal Detail:
Title:  Neuropathology : official journal of the Japanese Society of Neuropathology     Volume:  -     ISSN:  1440-1789     ISO Abbreviation:  -     Publication Date:  2010 Mar 
Date Detail:
Created Date:  2010-3-26     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9606526     Medline TA:  Neuropathology     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Human Pathology, University of Messina, Messina, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effects of lidocaine on esophageal secondary peristalsis in humans.
Next Document:  Non-Langerhans cell histiocytosis with isolated CNS involvement: an unusual variant of Erdheim-Chest...